EuroPCR 2022 Hotlines / Late-Breaking Trials in mitral and tricuspid: MITRA-TUNE, MitraBridge, TriCLASP, CLASP TR, and more!

Session comprising selected EuroPCR 2022 Late-Breaking Trial submissions

Facilitators: E. Ho, C. Tamburino
SHOW MORE

Summary

Find out more about various studies & registries in mitral and tricuspid! MitraClip in atrial functional mitral regurgitation, two-year outcomes of MitraClip as a bridge to heart transplantation, TriCLASP post-market study, CLASP TR study one-year results, Cardioband TR early feasibility study, and initial 30-day results from the TriClip bRIGHT study.

Presentations available when logged in:

  • MitraClip in atrial functional mitral regurgitation: a multicentre experience
  • Two-year outcomes of MitraClip as a bridge to heart transplantation
  • TriCLASP post-market study: 30-day outcomes
  • Transcatheter tricuspid valve repair: CLASP TR study one-year results
  • Cardioband TR early feasibility study one-year results
  • Real-world outcomes for tricuspid edge-to-edge repair: initial 30-day results from the TriClip bRIGHT study